When bladder cancer cell lines RT4 and T24 were treated with large doses of cisplatin, both ATP7A and ATP7B expression levels were significantly reduced, while CTR1 gene activity remained unaltered. This evidence concerns the gene ATP7A and urinary bladder cancer.